Condition
Vaccination; Complications
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Unknown2
Recruiting1
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04446832Recruiting
VACcination of LIver Transplantation Candidates
NCT03966391Not ApplicableCompletedPrimary
Effectiveness of CARD for Improving School-Based Immunizations
NCT04889326Unknown
Collection of the Thrombo-VaxCov Cohort
NCT05186571Unknown
Myopericarditis After Messenger Ribonucleic Acid (mRNA) COVID-19 Vaccination in Children 5-11 Years Old
NCT03966300Not ApplicableTerminated
Improving the School Vaccination Experience: What CARDs Are You Going to Play?
Showing all 5 trials